Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Bone graft & orthobiologics · Indiana | Bone graft & orthobiologics · Michigan | |
|---|---|---|
| Surgeons, 2024 | 13 | 27 |
| Medicare fee-for-service cases | 404 | 796 |
| Growth since 2019 (Medicare FFS) | −19%/yr | −14%/yr |
| Forecast cases (Medicare FFS) | 330 in 2030 | 740 in 2030 |
| Forecast growth | −3.2%/yr to 2030 | −1.1%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 0.6 | 0.9 |
| Medicare Advantage share | 53% | 66% |
| Out of hospital | 0% (−1 pts since 2019) | 3% (+2 pts since 2019) |
| Cases per surgeon | 31 | 29 |
| Top 10 surgeons' share | 89% | 60% |
| Surgeons growing | 1 | 2 |
| New since the base year | 0 | 2 |
| Likely to stop billing it | 5 by 2026 | 10 by 2026 |
| Forecast miss, 1 year (procedure) | 12% | 12% |
| Company payments per surgeon | $7,242 | $5,896 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.